Texan Cardiovascular Institute is categorized under Noncommercial Research Organizations in El Paso, TX and active since 2013.
Texan Cardiovascular Institute was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 3270 Joe Battle Boulevard, El Paso, Texas TX 79938 or by phoning (915) 307-2765. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Texan Cardiovascular Institute |
| Address: | 3270 Joe Battle Boulevard, El Paso, Texas 79938 |
| Phone Number: | (915) 307-2765 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Research Organizations |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Texan Cardiovascular Institute was started in 2013 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Texan Cardiovascular Institute by calling the company number (915) 307-2765, as your correspondence is most welcome. Additionally, the physical location of the single location of Texan Cardiovascular Institute can be found at the coordinates 31.789464,-106.267515 as well as the street address 3270 Joe Battle Boulevard in El Paso, Texas 79938.
For its online presence, you may visit Texan Cardiovascular Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.